Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 14 Aug 2024 | 6 Aug 2024 |
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended on June 30 2024 | ||
Board Meeting | 7 Aug 2024 | 7 Aug 2024 |
Appointment of Additional Independent Director(s). | ||
Board Meeting | 18 May 2024 | 12 May 2024 |
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024. Financial Results for Quarter and Financial Year ended March 31,2024 (As Per BSE Announcement Dated on 18.05.2024) | ||
Board Meeting | 31 Jan 2024 | 24 Jan 2024 |
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results. Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 31/01/2024) | ||
Board Meeting | 24 Jan 2024 | 16 Jan 2024 |
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve fund raising through Rights issue. The Board Meeting to be held on 24/01/2024 Stands Cancelled. Further to our letter dated January 16, 2024, intimating the exchange about the Board Meeting to be held on January 24, 2024, we further wish to inform that the agenda items are amended as below: (As per BSE Announcement Dated on 17/01/2024) Issue Of Warrants & Preferential Issue of shares & Rights Issue (As per BSE Bulletin dated on 17/01/2024) Outcome of Board Meeting (As Per BSE Announcement dated on 24.01.2024) | ||
Board Meeting | 9 Nov 2023 | 31 Oct 2023 |
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the Half year and quarter ended September 30 2023. Outcome of Board Meeting Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September,2023 along with Review Report issued by M/s J C Ranpura & Co. Chartered Accountant for the quarter /half year ended 30th September,2023 Financial Results for September 30, 2023 (As Per BSE Announcement Dated on 09/11/2023) |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice